Clara Sophie Turner

Clara Sophie Turner

Auto-generated profile, based on publicly available information

Clara Sophie Turner

Department of Nephrology and Endocrinology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Ophthalmology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2026 in Diabetes Research and Clinical Practice
Verified
Journal Article
Open access
CTClara Sophie Turner
Clara Sophie Turner
MHMads Hornum
Mads Hornum
EBEllen Linnea Freese Ballegaard
Ellen Linnea Freese Ballegaard
NCNicholas Carlson
Nicholas Carlson
SHSteffen Heegaard
Steffen Heegaard
DKDea H. Kofod
Dea H. Kofod
Although albuminuria is an established prognostic marker in individuals with diabetes and chronic kidney disease (CKD), less is known about the association between albuminuria and retinal and neurological complications in large, unselected populations with type 2 diabetes and established CKD. We investigated the association of urine albumin-creatinine-ratio (UACR) on prevalence and incidence of microvascular complications in individuals with CKD. We included 27,924 adults with type 2 diabetes and CKD (eGFR < 60 ml min⁻1 1.73 m2⁻1) from Danish health care registers (2010-2023). Outcomes included diabetic retinopathy, polyneuropathy, and progression of CKD. Odds of retinopathy and polyneuropathy at baseline were evaluated using logistic regressions. Standardized 5-year risks of outcomes ere estimated using Cox regressions across UACR strata (1000 mg/g). Median age was 75 years (IQR 69-80), 41.5% were female, and median eGFR was 53 ml min⁻1 1.73 m2⁻1 (IQR 47-56). Odds ratios for diabetic retinopathy and polyneuropathy were positively correlated with UACR. 5-year risks (95% CI) of all outcomes were similarly associated with increasing UACR levels. Albuminuria was associated with a progressive increase in prevalence and incidence of microvascular disease in individuals with type 2 diabetes and CKD.